Since its outbreak in December 2019, COVID-19 has hit the whole world including Europe, and the EMR is heavily influenced as well. Currently, the knowledge on the spread of the COVID-19 in the population in relation to the compliance with infection prevention measures is limited, but this is the basis to monitor the disease and to impose measures or lift measures. Therefore, this project is developed to collect data on infection prevalence and on infection prevention behaviours, collectively and comparatively in all the three EMR countries.
Final target group: EMR citizens
Duration of the project: 1 August 2020 – 31 July 2021
Main funder: Interreg EMR
Project partners: GGD Zuid Limburg, euPrevent EMR, Sciensano, Maastricht UMC+, Gesundheitsamt des Kreises Heinsberg, Gesundheitsamt Düren, Gesundheitsamt der Städte Region Aachen, Deutschsprachige Gemeinschaft Belgiens.
Focus of the project
The goal of the project is to assess the impact of COVID-19 on the EMR: through relating the prevalence of COVID-19 antibody with the response measures taken so that we can gain some insight on the effects of COVID-19 in a cross-border region like the EMR, and to present this as a showcase for other border regions in the EU (or even broader) on what the effects could be for other border regions.
Research: Two rounds tests of blood samples will take place in order to see the evolvement of COVID-19 antibodies among EMR citizens as a reaction to the various response measures. Regional citizen summits will be organized in their own languages where the voices of the citizens will be heard on how they experience the COVID-19. A conference will be organized where the first result of this project will be presented and where the first draft of the recommendations report will be discussed with experts from all over the EMR and outside.
In addition to the final report that covers the findings of the research and the regional citizen summits, an infographic will be drawn upon the result of the report for better illustration, and all the data acquired through the project will be visualized on the Euregional Health Atlas (EHA).